Video

Dr Debra Patt on What In-person Attendees Can Expect at the Community Oncology Conference

Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, speaks on the key discussions to be held at the 2022 Community Oncology Conference for in-person attendees.

By bringing together administrators, clinicians, and policy makers within community oncology, in-person attendees at the 2022 Community Oncology Conference can discuss issues facing their respective practices and formulate collaborative solutions, said Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.


Transcript

What can providers and those involved in community oncology gain by being an in-person attendee at the 2022 Community Oncology Conference?

I think that we've all missed seeing each other for the last 2 years, but we've encountered a whole new slew of challenges. The benefit of going to the Community Oncology Alliance meeting is like no other meeting.

It allows you to meet with like-minded individuals that are in community oncology practice—administrators, clinicians, policy makers—and discuss the problems that you've had and formulate collaborative solutions so you can learn from what everyone else is doing. It's a great forum for that and to discuss with people what resources you've developed and share them.

Related Videos
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
AMCP Recap 2025
Giulio Cossu, MD
Lynae Darbes, PhD
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo